China Promotes Distribution of Medicare-covered Drugs Through "Double Channel"

China permits qualified drug stores to sell prescription drugs included in the National Reimbursement Drug List. At these drug stores, people can enjoy the same medical care payment coverage with hospitals. The policy intends to add another sales channel for the drugs outside hospitals, especially for the newly listed drugs through centralized procurement.
by Grace Wang May 24, 2021

On May 10, 2021, China National Healthcare Security Administration (NHSA) and National Health Commission (NHC) published a guidance on improving the "double channel" management system1 for drugs covered by social healthcare insurance. The drugs are also known as the medicines in the National Reimbursement Drug List (NRDL)

Grace Wang
ChemLinked Regulatory Analyst
+ FOLLOW
Copyright: unless otherwise stated all contents of this website are ©2021 - REACH24H Consulting Group - All Rights Reserved - For permission to use any content on this site, please contact cleditor@chemlinked.com